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Summary 
The MHC class II-associated invariant chain interacts in trimeric form with class II molecules, 
inhibits peptide binding, and mediates targeting ofdass II molecules to endosomal compartments. 
To dissect the different functions of the invariant (Ii) chain, a set of cDNAs, encoding truncated 
forms of the Ii chain, was constructed, mRNAs, transcribed from these cDNAs were translated 
in vitro, together with mRNAs encoding dass II HLA DR1 ot and B subunits. An Ii chain 
truncation that contains the 104 NH2-terminal amino acids was able to associate with class II 
molecules. This construct contains the region from which class II-associated Ii chain peptides 
(CLIP, amino acids 81-104) are derived. The absence of a further eight residues at the COOH 
terminus results in a construct of 96 amino acids that is unable to associate with class II molecules. 
Association of the truncated Ii chains with class II molecules showed a strict correlation with 
inhibition of peptide binding. Removal of the NH2-terminal cytoplasmic taft and transmembrane 
region of Ii chain and its replacement with a cleavable signal sequence led to aberrant folding 
and impaired association with class II molecules. The region between amino acids 163 and 183 
was found to be essential for visualization of Ii chain homotrimers by covalent cross-linking. 
M 
HC class II molecules are expressed at the cell surface 
where they present peptides to T  cell receptors of 
CD4 + cells. Class II molecules are composed of two MHC- 
encoded subunits, the oe and/~ chain, which associate in the 
endoplasmic reticulum (EK) 1 with a third protein, the in- 
variant (Ii) chain. This association is rapid and efficient, due 
to a large molar excess of the Ii chain in cells expressing class 
II molecules (1, 2). Ii chains assemble into homotrimers in 
the EK (3), and form higher order structures upon associa- 
tion with ol and 3  chains (4,  5).  These oligomers consist 
ofli chain homotrimers with one, two, or three cr  hetero- 
dimers attached. 
The Ii chain is a type II membrane protein with a non- 
cleavable signal anchor sequence. The NH2-terminal tail is 
exposed in the cytosol, while the COOH-terminal bulk of 
the protein forms the lumenal domain (6). Alternative splicing 
and the use of different translation initiation sites lead to at least 
four different forms of Ii chain in humans, with a Mr of 33, 
35, 43, 45 kD, respectively  (7), of which the 33-kD form 
(p33) is the most abundant. The protein is modified cotrans- 
lationally by N-linked and posttranslationally by O-linked 
glycosylation (6,  8,  9). 
1  Abbreviations used in thispaper: CLIP, dass II-associated Ii chain peptides; 
DSP, dithiob/s (succinimidylpropionate);  endo H, endoglycosidase H; ER, 
endoplasmic reticulum; HA, hemagglutinin; Ii, invariant. 
Four functions have been assigned to the Ii chain: (a) as- 
sociation with class II molecules and facilitation of egress of 
class II out of the ER (10-12);  (b)  homotrimerization to 
generate a scaffold onto which ol/~ heterodimers assemble 
(4, 5); (c) inhibition of peptide binding by class II molecules 
(13, 14); and (d) targeting class II molecules to the endocytic 
pathway (15, 16). In the endosomal compartments, the Ii chain 
is degraded to allow subsequent binding ofpeptide (17). Two 
of the functions have been attributed to specific regions of 
the Ii chain. A sequence in the cytoplasmic tail functions as 
a signal to target ot//~-Ii complexes to endosomal compart- 
ments (15, 16). The region between amino acids 87 and 110 
of the mouse Ii chain (which corresponds to the same posi- 
tions in the human p33 Ii chain) is essential for association 
with class II molecules (18). 
Peptides derived from Ii chain have been eluted from both 
mouse and human class II molecules (19-22). These peptides, 
designated class II-associated Ii chain peptides (CLIP), vary 
in length between 14 and 25 amino adds. They originate 
from the region between amino acids 81 and 104 in human 
p33 and mouse Ii chain. Their discovery led to the specula- 
tion that (a) Ii chains interact with class II ol/B heterodimers 
via the CLIP region and (b) that this interaction occurs in 
the peptide binding groove and thereby prevents peptide 
binding of class II molecules. 
We investigated domain-function relationships of the Ii 
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II cr and 3 chains. We show that amino acids 96-104, located 
in the CLIP region, are essential for interaction with class 
II ot and 3 chains in vitro. The ability of Ii chain truncations 
to inhibit peptide binding coincided with their ability to as- 
sociate with class II molecules. The region between amino 
acid 163 and 183 was found to be required for the visualiza- 
tion of Ii chain  homotrimers by covalent cross-linking. 
Materials  and Methods 
DNA Constructs.  CDNAs encoding the HLA-DR1 ce (23) and 
chains (24) were kindly provided by Dr. J. Trowsdale (Imperial 
Cancer Research  Fund, London, UK). cDNA encoding the p33 
Ii chain (6) was kindly provided by Dr. B. Dobberstein (Zentrum 
fiir Molekular Biologic Heidelberg, Heidelberg, Germany). The 
cDNA encodes the "long" form of Ii, referred to by others as p35. 
The sequence encoding the cleavable signal peptide of the class II 
3 chain was exchanged for the sequence encoding the signal pep- 
tide of mouse class I heavy chain H2-K  b, to obtain approximately 
equal translation and translocation efficiencies for ot and 3 chains. 
All cDNAs were cloned into pSP72  (Promega Corp., Madison, 
WI) behind the T7-RNA polymerase promoter. 
mRNAs encoding COOH-terminal truncations of the Ii chain 
were generated in two different ways. 163C, 123C, and 104C were 
generated by restriction enzyme digestion of the full-length Ii chain 
cDNA with DrdI, AvalI, and NcoI, respectively, which cut in the 
coding sequence of Ii chain. Plasmids linearized with these enzymes 
were used for the transcription ofmRNA. 183C, 153C, 96C, and 
80C were generated by introduction ofa BamHI site (by PCR with 
the enzyme PFU [Stratagene,  La Jolla, CA]) after the codons en- 
coding amino acid 183, 153, 96, and 80, respectively. PCR prod- 
ucts were digested with EcoRI and BamHI and subcloned in pSP72 
(Promega Corp.). After linearization with BamHI, mRNA was 
transcribed from these cDNAs. 
cDNAs encoding NH2-terminally truncated Ii chains, fused to 
the signal  peptide of H2-K  b, were generated by two-step PCR 
reactions (using the enzyme PFU). Two reactions were performed 
in the first step. In one reaction Ii chain fragments were generated, 
using a 5' primer with an overhanging sequence complementary 
to  the H2-K  b signal  peptide cDNA.  In  the  other reaction an 
H2-K  b fragment was generated, using a 3' primer with an over- 
hanging sequence complementary to Ii chain cDNA. In the second 
step, PCR fragments of both reactions were annealed and a fusion 
product of both cDNA fragments was  synthesized by PCR. 
Antibodies and Peptides.  The following anti-HLA-DR1 antibodies 
were used: the mouse mAb Tfi36 (25), a generous gift of Dr. Zie- 
gler (Frieie Univers~te, Berlin, Germany), the mouse mAb LB3.1, 
kindly provided by Dr. J. Strominger (Harvard University, Cam- 
bridge, MA). Two Ii chain-reactive mouse mAbs were used: Vic- 
Y1 (26), which is specific for the NH2 terminus and was kindly 
provided by Dr. W. Knapp (University of Vienna,  Vienna,  Aus- 
tria)  and BfJ45 (27) directed against  the COOH terminus (from 
The Binding Site, Ltd., Birmingham, UK). The FILA-DR1 present- 
able peptide from influenza virus hemagglutinin (HA) (306-318) 
(28) was a generous gift of Dr. L. Stern (Harvard University). Pep- 
tides  were dissolved in H20 and stored at  -20~ 
Gel Electrophoresis.  SDS-glycine  gel electrophoresis were per- 
formed as described (29). SDS-glycine gels were fluorographed using 
dimethylsulfoxide-diphenyloxazole  (DMSO-PPO) and exposed to 
Kodak XAR-5 films. 
In Vitro Transc@tion  and In Vitro Translation.  Transcriptions were 
performed using T7 RNA polymerase.  RNA was stored in 70% 
ethanol. The optimal amount of RNA for translation was deter- 
mined empirically for each separate batch of RNA. 
In vitro translations were performed with rabbit reticulocyte ly- 
sate, not supplemented with dithiothreitol (Flexi~; Promega Corp.), 
in the presence of dog pancreas microsomes (Promega Corp.). Trans- 
lations were performed for 60 min at 30~  Typical translation reac- 
tions contained 17.5 #1 rabbit reticulocyte lysate, 1.5 #1 dog pan- 
creas microsomes, 0.8 #1 2.5 M KC1, 0.5 pl 10 mM amino acid 
mixture minus methionine, and 2.5/d [3SS]methionine  (10 mCi/ml; 
DuPont, Wilmington, DE), 1-3 #1 mRNA dissolved in diethylpy- 
rocarbonate-treated H20 (total reaction volume 25/~1). 
ImmunotnrcilJitation.  After translation, microsomes were pelleted 
by centrifugation at 14,000 rpm for 10 min at 4~  and subsequently 
lysed in 200 #1 NP-40 tysis buffer (0.5% NP-40, 50 mM Tris-FIC1, 
pH 7.4, 5 mM MgC12). Solubilized  microsomes were either sub- 
jected to immunoprecipitations immediately or incubated on ice 
in the presence of peptides  as described in the figure legends.  Be- 
fore immunoprecipitations, the volume was increased to 1 ml by 
the addition of NP-40 lysis buffer. Nonspecifically bound proteins 
were removed by preclearing twice with 3/~1 normal rabbit serum 
for 45 min and 50 pl formaline fixed, heat-killed Staphylococcus  aureus 
Cowan strain  bacteria  (Staph.A;  10%  vol/vol) for 30 min.  Irn- 
munoprecipitations were performed with 2 #t ascites or polyclonal 
serum for 1 h on ice. Immune complexes were removed by adsorp- 
tion onto 50/~1 Staph.A. Pelleted bacteria were washed four times 
in buffer containing 0.5% NP-40, 50 mM Tris-HCl, pH 7.4,  150 
mM NaC1,  and 5 mM EDTA.  Bound immune complexes were 
eluted in reducing SDS-sample buffer for 5 min at 95~  and sub- 
jected to SDS-polyacrylamide  gel electrophoresis.  To detect "SDS- 
stable" class II ce/3 heterodimers, Staph.A pellets were extracted 
for 20 min with SDS-sample buffer (4% SDS final concentration) 
at room temperature before gel electrophoresis. 
Endo H l~'gestion.  For endoglycosidase  H (endo H) digestion, 
immune complexes adsorbed to Staph.A were divided into two equal 
portions. Both portions were denatured in 0.5% SDS, 1% 3-mer- 
captoethanol for 5 rain at 95~  After cooling on ice, reaction buffer 
(50 mM sodium citrate,  pH 5.5) was added to every sample and 
recombinant endo H  (New England Biolabs  Inc., Beverly, MA) 
was added  to one half of the samples at a final concentration of 
50,000 U/ml. The remaining half of the samples served as mock 
digestion control. All samples were incubated at 37~  for 60 rain. 
Cross-linking with DSP.  For cross-linking experiments, micro- 
somes were lysed in 0.5% NP-40 in PBS containing the cleavable 
homobifunctional cross-linker  dithiobis (succinimidylpropionate) 
(DSP)  (Pierce, Rockford, IL), at the concentrations indicated in 
the figure legends.  DSP was stored in DMSO at a concentration 
of 10 mg/ml. After incubation for 30 rain on ice, glycine was added 
to a final concentration of 250 mM to quench the cross-linking. 
After 30 min on ice, aggregates were removed by centrifugation 
at 14,000 rpm at 4~  for 20 min. Immunoprecipitations were per- 
formed as described above. Staph.A-bound immune complexes were 
eluted in nonreducing SDS-sample  buffer. 
~eSlllts 
Characterization  of Truncated Ii Chains  Translated In  Vitr~ 
Deletions at the 3' or 5' end of the human Ii chain cDNA 
were made as described in Materials and Methods. The proteins 
encoded by these cDNAs have deletions of various lengths 
at the COOH  or NH2 termini of the p33 Ii chain (Fig.  1 
a). The constructs are designated by the position of their first 
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full-length, the  NH2-terminally,  and COOH-terminally truncated  li 
chains. Truncations were made as described in Materials and Methods. The 
position of the last amino acids of the COOH-terminal truncations are 
indicated on the right, the position of the first amino acids of the NH2- 
terminal truncations are indicated on the left. Further indicated are: the 
transmembrane  region (TM), the region from which CLIP are derived 
(CLIP), the glycosylation sites (arrows), and the signal peptide of H2-K  b 
(SP). (b) mRNAs encoding the fun-length Ii chain (Ii) or COOH-terminaUy 
truncated forms of the invariant  chain were translated in vitro in the pres- 
ence of microsomes. Microsome-associated  products were subjected to im- 
munoprecipitation with mAb Vic-Y1 (I  o, against the NH2 terminus or 
Bii45 (B), against the COOH terminus. Polypeptides  recovered  with Vic-Y1 
were either mock digested (-) or digested (+) with endo H  to remove 
N-linked carbohydrate  chains.  Glycosylated polypeptides  are indicated 
(aster~k). Immunoprecipitates were analyzed on reducing 12.5% polyacryl- 
amide gels. Dimers of full-length  li chain, 183C, and 163C were detected. 
These are formed by interchain disulfide bridge formation between the 
(for the NH2-terminal truncations) or last (for the COOH- 
terminal truncations) amino acid. Thus, 183C encodes amino 
acids 1-183 and N81 contains amino acids 81-216.  mRNAs 
were transcribed from these cDNAs and translated in vitro 
using rabbit reticulocyte lysate in the presence of microsomes 
as ER equivalents.  The NH2-terminally truncated forms, 
which do not contain the Ii chain signal peptide, were fused 
with the cleavable signal peptide of mouse MHC class I heavy 
chain H2-K  b to ensure translocation into microsomes. 
Translation products associated with microsomes were im- 
munoprecipitated and analyzed by SDS-PAGE (Fig. 1, b and 
c). Translation of full-length Ii chain mRNA resulted in two 
products which were recognized equally well by mAb Bii45 
(27)  directed against  the COOH  terminus,  and by mAb 
Vic-Y1, directed against the NH2 terminus of Ii chain (26) 
(Fig.  1 b). The difference between these two polypeptides 
is not due to heterogeneity of glycosylation, since removal 
of N-linked carbohydrate chains with endo H  still resulted 
in  two  polypeptides  (Fig.  1  b).  The  COOH-terminaUy 
truncated Ii chains gave rise to two precursor proteins per 
mRNA as well, both of which were recognized by Vic-Y1 
(Fig. 1 b). Translation of NH2-terminally truncated Ii chains 
resulted in only one translation product (Fig. i c) per mRNA. 
The difference between the two fuU-length Ii chain poly- 
peptides therefore resides at the NH2 terminus, most likely 
as the result of alternative initiation of translation. In view 
of the positions of methionines throughout the Ii chain and 
the sizes of the two Ii chain translation products, alternative 
initiation at position 15 is most probable (6).  Initiation at 
the next methionine, at position 60, would have resulted in 
the absence of the cytoplasmic tail and therefore in the absence 
of the Vic-Y1 epitope. 
The mAb Bii45,  directed against  the Ii chain lumenal 
portion, recognized 183C and to some extend 163C, but not 
153C (Fig. 1 b). The region COOH-terminal of amino acid 
163 must therefore be important for the generation of the 
epitope recognized by this antibody. (Translation  of 163C 
in this experiment produced the full-length Ii chain in addition 
to the truncated Ii chain. This is the result of incomplete 
digestion of the Ii chain cDNA with restriction enzyme DrdI 
before in vitro transcription, which was used to delete the 
COOH-terminal encoding part of the cDNA [see Materials 
and Methods].) The NHz-terminal deletion constructs were 
ef~ciently translated and translocated into microsomes. This 
was followed by cleavage of the H2-K  b signal sequence (data 
not shown) and N-linked glycosylation of N81  and Nl10 
as expected (Fig.  1 c). However, immunoprecipitation with 
Bfi45, against the COOH terminus, was very inef~cient (Fig. 
1 c). The loss of the Bfi45 epitope suggests that absence of 
the  transmembrane  region  and  cytoplasmic tail  leads  to 
misfolding of the remainder of the protein. 
cysteine in the cytoplasmic tail. Migration of marker proteins are shown 
on the right. (c) mRNAs encoding NH2-terminally  truncated Ii chains 
were translated in vitro. Microsome-associated products were divided into 
two parts and either directly loaded on gel (-) or immunoprecipitated 
with Bii45 (B). Samples were either mock treated (-) or digested with 
endo H  (+). 
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truncations shorter than 183 amino acids, leading to genera- 
tion of two backbone and two glycosylated  polypeptides (Fig. 
I b). The use of consensus glycosylation acceptor sequences 
(Asn-X-Thr/Ser) is thought to be dependent on the context 
in which they occur. Deletion of COOH-terminal sequences 
apparently leads to reduced accessibility of the glycosylation 
acceptor sites. For 104C and 96C (and 80C, Fig. 2) an endo 
H-sensitive polypeptide was observed in addition to two prod- 
ucts of the expected size, although these constructs do not 
contain glycosylation acceptor sites. The occurrence of this 
aberrant  polypeptide  is not due to glycosylation of one of 
the properly sized chains, as removal of carbohydrates with 
endo H showed the appearance of a polypeptide of distinct 
mobility. The aberrant products were reactive with Vic-Y1, 
indicating that transhtion initiation was correct and had gener- 
ated a cytoplasmic tail of  the proper sequence. The possibility 
of  a mutation in the cDNAs was excluded by DNA sequence 
analysis, which gave the expected primary structure. The syn- 
thesis of this glycosylated  polypeptide can neither be explained 
by a shift in reading frame during translation,  since the alter- 
native two reading frames also do not contain glycosylation 
sites. We have not determined the exact location of attach- 
ment of this endo H-sensitive glycan, and have not found 
a satisfactory explanation  for this  phenomenon so far. 
The COOH-terminally truncated constructs otherwise be- 
haved in accordance with expectations as far as size, glycosy- 
lation,  and reactivity with mAbs is concerned. 
Amino Acids 96-104, Located in the CLIP Region, Are Re- 
quired for Association with  Class II ot/~ Heterodimers.  The 
ability of truncated Ii chains to associate with class II mole- 
cules was investigated by in vitro translation  of these con- 
structs together with dass II HLA-DR1 ot and B subunits 
in the presence of  microsomes. After translation, microsomes 
were sedimented, lysed in detergent, and the extracts were 
subjected to immunoprecipitation. Interaction between Ii chain 
truncations and class II molecules was detected by immuno- 
precipitation with the following antibodies: mAb Tti36, which 
recognized both a/B heterodimers and o~//~-Ii heterotrimers; 
mAb LB3.1, which recognizes or//5 heterodimers  but not 
a/B-Ii  heterotrimers;  and mAb Vic-Y1, which recognizes 
both free Ii chain and Ii chain associated with class II mole- 
cules. All truncated Ii chains that extend beyond position 100 
at the COOH terminus, were recovered with Tii36 and thus 
interact sufficiently strongly with class II molecules to sur- 
vive immunoprecipitations (Fig. 2). In contrast to the full- 
length Ii chain,  the COOH-terminally truncated Ii chains 
were also recovered with LB3.1 (Fig. 2). In metabolically la- 
beled cells, this antibody recognizes ct//~ heterodimers only 
after dissociation of the Ii chain. The COOH-terminal re- 
gion of the Ii chain is thus responsible  for obscuring the LB3.1 
epitope on class II molecules. Immunoprecipitation of 104C 
and 153C with Vic-Y1 likewise showed association with ol 
and/3 chains (Fig. 2). Coimmunoprecipitation of ot and B 
chains with Vic-Y1 was completely  inhibited in the presence 
of a synthetic Ii chain-derived peptide (residue 1-27)  that 
is recognized by Vic-Y1 (data not shown). Note that pre- 
dominantly the correctly glycosylated 153C polypeptides as- 
sociated with class II molecules, whereas  the unidentified 
aberrantly glycosylated 100C polypeptide  did not (Fig. 2). 
Constructs 96C and 80C showed no trace of association with 
class II molecules, based on immunoprecipitation  with T~i36 
and LB3.1 (Fig. 2). The amount of o~ and B chains recovered 
with Vic-Y1 from the translation with 100C was similar to 
that detected in the absence of Ii chain construct (data not 
shown), and can therefore be considered background level. 
Thus, the short region between amino adds 96 and 104, which 
constitutes the eight COOH-terminal amino acids of the CLIP 
region, is essential for association of Ii chains with class II 
molecules. Deletion of the lumenal domain of Ii chain, be- 
yond what is minimally required for interaction  with class 
II molecules, has no effect on the formation of stable com- 
plexes. The NH2-terminal  truncation N81, which contains 
the region essential for association, did not associate with 
class II molecules (data not shown). This confirms our no- 
tion that soluble forms of Ii chain produced in this manner 
are folded incorrectly. 
Association of Truncated  Ii Chains with ol/~ Heterodimers  Corre- 
lates with Inhibition of  Peptide  Binding.  The presence  of  Ii chain 
precludes peptide binding to purified class II molecules (13). 
Binding of peptide can be monitored by the generation  of 
SDS-stable c~//J dimers. These dimers do not dissociate upon 
incubation with SDS at room temperature,  and can thus be 
visualized by SDS-PAGE. Boiling of the samples leads to full 
Figure 2.  Amino acids  between 96 and 104 
are essential for association with class II ot/B 
heterodimers. Full-length or COOH-terminally 
truncated Ii chains were translated in vitro to- 
gether with class II HLA-DR1 ct and/~ chains. 
Detergent lysed microsomes of these transla- 
tions were divided into three equal parts and 
immunoprecipitated  with  mAbs Tit36 (T), 
which recognizes class II molecules regardless 
of the presence of Ii chain, LB3.1 (L), which 
recognizes free ot//~ complexes but not (full- 
length) Ii chain-associated ct//~ complexes, and 
Vic-Y1 (V), against the cytoplasmic tail of Ii 
chain. Immunoprecipitates  of ct//~104C were 
analyzed  on  a  10%  polyacryl-amide  gel, 
whereas the other immunoprecipitates were analyzed on 12.5% gels. These conditions are responsible for the difference in migration of c~ and fl chains 
between this translation and the others  and the apparent  faster migration of 104C compared with 96C. 
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vents peptide binding by class II molecules. Class II HLA-DR1 c~ and 
3 chains  were  translated  either  alone  or in the presence  of  COOH-terminal 
truncations of the Ii chain (123C, 153C, and 104C). After translation, 
detergent lysed  microsomes  were incubated  with HLA-DR1  presentable 
peptide HA (306-308) (10 #m) for 16 h on ice. Subsequently,  extracts 
were divided  into two equal portions and subjected  to immunoprecipita- 
tions with either mAb Tfi36 (T), specific  for class II complexes,  or mAb 
Vic-Y1 (V), specific  for Ii chain. One half of the Staph.A-bound com- 
plexes were extracted at room temperature in SDS-sample buffer (Boil: 
-), to allow  detection  of SDS-stable e~/3 dimers, the other half  was ex- 
tracted at 95~  (boil: +). The position of the SDS-stable or  dimers 
(oe/3), as well  as that of free c~ and/~  chains and Ii chain truncations  are 
indicated. 
dissociation of these complexes into oe and 3 chains. Transla- 
tion of c~ and 3 chains, followed by incubation with the HLA- 
DR1 presentable peptide from influenza HA (306-318),  led 
to recovery of SDS-stable  dimers (Fig.  3).  Translation of oe 
and 3  chains together with Ii chains leads to a mixture of 
or~[3 heterodimers and c~/3-Ii heterotrimers, of which only 
the cz/3 heterodimers are able to bind peptides, consistent 
with inhibition of peptide binding by the presence of Ii chain 
(29a). 
To analyze which part  of the Ii chain is responsible for 
inhibition of peptide binding, we investigated the ability of 
COOH-terminal truncations to carry out this function. Trans- 
lation of either 104C,  123C,  or 153C  together with o~ and 
3  chains was followed by incubation with HA (306-318). 
This resulted in formation of complexes that were detectable 
with mAb Vic-Y1,  against the Ii chain and T(i36, against 
a/[3 complexes (Fig.  3).  However, SDS-stable  oe/3 dimers 
were recovered with mab TLt36 only (Fig. 3, lanes 4, 6, and 
11), and not with Vic-Y1 (Fig. 3, lanes 7-10, 12). This indi- 
cates that o~/3 heterodimers associated with Ii chain trunca- 
tions do not contain peptide. Thus, interaction of Ii chain 
truncations with oe/3 heterodimers leads to inhibition pep- 
tide binding. 
The Ii Chain Region Between Amino Acids 163 and I83 Is 
Involved in the Formation of li Chain Homotrimers.  In living 
cells, Ii chains assemble into homotrimers soon after synthesis 
(3). Trimerization could be demonstrated for Ii chains trans- 
lated in vitro as well, when the homobifunctional cleavable 
cross-linker DSP was added shortly after lysis of microsomes. 
Increasing concentrations of DSP led to increasing amounts 
of trimers, and concomitantly decreasing amounts of mono- 
mers and dimers (Fig. 4). The Ii chain homodimers were de- 
tected independently of the presence of cross-linker under these 
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Figure 4.  The region  between amino  acids 163 and 183 is important 
for visualization  of homotrimerization  by cross-linking,  mRNAs  of full- 
length or COOH-terminally  truncated Ii chains were translated. After 
translation, microsomes  were  pelleted  and lysed  in 1 ml 1% NP-40  in PBS. 
The lysed  microsomes  were divided  into five equal parts and the cross- 
linker  DSP was added  at the indicated  concentrations.  Quenching  of  cross- 
linker with glycine  and removal of aggregates were done as described  in 
Materials  and Methods.  Vic-Y1 immunoprecipitates  were  analyzed  on 10% 
SDS-poly-acrylamide  gel under  nonreducing  conditions.  The positions  of 
the monomers  (I), dimers (2), and trimers (3) are indicated. The arrow 
indicates the nonglycosylated  form of 163C. 
nonreducing electrophoresis conditions. Their generation is 
most likely due to interchain disulfide bridge formation via 
the single cysteine located in the cytoplasmic tail of the Ii 
chain. Truncation 183C (which lacks the last 33 amino acids) 
showed the same oligomerization pattern as the full-length 
Ii chain (Fig.  4).  However,  163C  formed no homotrimers 
whatsoever, whereas homodimers were detected independently 
of the presence of DSP (Fig. 4). The stretch of amino acids 
between position 163 and 183 is therefore essential  for the 
detection of homotrimers with DSP.  Lysines,  the e-NH2 
groups of which are the main target for cross-linking by DSP, 
are absent from this region. This leads us to conclude that 
the cross-linking occurs at a site NH2-terminal  of residue 163. 
Discussion 
We have located two distinct functional regions in the lu- 
menal part of the Ii chain by using in vitro translation of 
truncated Ii chains.  The first segment is involved in forma- 
tion of cross-linkable  Ii chain homotrimers and is located be- 
tween amino acids  163 and 183. This segment is likely to 
contribute to the architecture of the Ii chain trimer. Ii chain 
lacking this segment might still form trimers, which can no 
longer be cross-linked  covalently. The second segment is in- 
volved in association of Ii chain with class II c~/3 heterodi- 
mers and located closer  to the membrane, between amino 
acids 96 and 104. We observed that replacement of the trans- 
membrane region and cytoplasmic tail by a cleavable signal 
sequence results in misfolding of the lumenal part of Ii chains 
even though membrane insertion and glycosylation  take place 
as expected. 
Association with Ii chain determines the function of class 
II molecules in antigen presentation (8,  9).  In contrast to 
class I molecules, which bind peptides from endogenously synthesized proteins in the ER, class II molecules bind pep- 
tides from endocytosed proteins in endosomal compartments 
to which they are targeted by the Ii chain (15, 30-32).  Inter- 
action with Ii chain prevents peptide binding by class II mol- 
ecules, but how this is executed and what region of the Ii 
chain is involved in this process is not understood. Two alter- 
native mechanisms are plausible: (a) the Ii chain binds in the 
peptide binding groove and thus competes for antigenic pep- 
tide or (b) it binds outside the groove and prevents peptide 
binding by steric hindrance or by inducing a conformational 
change in the peptide binding domain. 
Peptides derived from the Ii chain (CLIP peptides) have 
been eluted from several  mouse and human dass II molecules. 
These peptides originate from a region that is highly con- 
served between mouse, human, and rat (between amino acids 
81 and 104 in mouse and human p33 Ii chain) (18). In in 
vitro peptide binding experiments, CLIP peptides e~ciently 
compete with class II presentable peptides (21, 22) and in- 
cubation of empty class II molecules with CLIP peptides 
leads to generation of SDS-stable molecules (22, 29a). Thus, 
the CLIP peptides most likely bind in the peptide binding 
groove. Two possible processes could explain the binding of 
Ii chain-derived peptides: either the CLIP peptides are gener- 
ated in the endocytic compartment by degradation of the dis- 
sociated Ii chain, or the CLIP region represents the region 
of Ii chain that interacts with class II molecules and remains 
associated after degradation  of the Ii chain. 
Freisewinkel et al. (18) have shown for the mouse Ii chain 
that the region between amino acids 87 and 110 (which cor- 
responds to the same region in human p33 Ii chain) is essen- 
tial for association with class II molecules. This result was 
obtained by transfecting COS cells with Ii chains carrying 
internal deletions rather than truncations.  We have defined 
an even shorter region, between amino acids 96 and 104, with 
a similar function for the human Ii chain. Both the mouse 
and human segments essential for interaction  with class II 
c~/~ complexes, are located within the CLIP region (amino 
acids 81-104). 
Freisewinkel  et al. (18) pointed out that the membrane prox- 
imal location of the CLIP region does not agree with binding 
of the intact Ii chain via this region in the peptide binding 
groove of class II molecules. Indeed, only 24 amino acids sep- 
arate the transmembrane region (residues 29-56) and the first 
amino acid of the CLIP region (residue 81) (Fig. la). How- 
ever, the "core" of the CLIP peptides (which are sets of pep- 
tides overlapping at COOH terminus as well as NH2 ter- 
minus) is located  10  amino acids further away from the 
transmembrane region (at position 91). Chicz et al. (33) cal- 
culated that the length of the stretch of amino acids between 
the CLIP and transmembrane region, either in an extended 
conformation or even as an c~ helix, may be sufficient to allow 
binding of the CLIP region in the peptide binding domain. 
In our experiments, interaction of truncated Ii chains with 
class II molecules could not be separated from their ability 
to prevent  peptide  binding;  even the shortest  class II-as- 
sociating  construct  (104 amino  acids) prevented  peptide 
binding. This indicates either that both functions are executed 
by the same region of the Ii chain or that the domain that 
inhibits  peptide binding is located  NHz-terminally of the 
domain essential for association with class II molecules. The 
COOH-terminal 102 amino acids do not seem to be not in- 
volved in either of these functions. 
The issue of Ii chain-class II interaction and the mecha- 
nism by which Ii chain prevents peptide binding will only 
be definitively settled by elucidation of the three-dimensional 
structure of the Ii chain. For this purpose, it will be neces- 
sary to produce crystals of Ii chains derived from membrane 
anchored forms. Removal of the cytoplasmic tail and the trans- 
membrane region leads to misfolding of the Ii chain in our 
in vitro translation system even though membrane insertion 
is successfully mediated by a cleavable NH2-terminal  signal 
sequence. In intact Ii chain, folding of the lumenal domain 
proceeds from a membrane tethered intermediate that appar- 
ently imposes constraints  on the folding pathway. This as- 
pect should be taken into account for successful folding of 
recombinant forms of Ii chain.  Homotrimerization of the 
Ii chain might play a role in the acquisition of the proper 
conformation as well, and thereby be important for the as- 
sembly of c~ and B chains. We have mapped a region involved 
in visualization of trimerization to amino acids 163-183. In- 
terestingly,  the stretch  between amino acids 150  and  173 
(_LRHLKNTMETIDWKVFESWMHHWI~_, underlined are 
the A and D positions) has the potential to fold into a am- 
phiphatic helix with the possibility to form a coiled coil (34) 
which could constitute an obvious element to bring about 
trimerization. 
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